• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旁分泌 Wnt 信号既能促进又能抑制人乳腺癌的生长。

Paracrine Wnt signaling both promotes and inhibits human breast tumor growth.

机构信息

Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

出版信息

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6991-6. doi: 10.1073/pnas.1303671110. Epub 2013 Apr 4.

DOI:10.1073/pnas.1303671110
PMID:23559372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3637696/
Abstract

Wnt signaling in mouse mammary development and tumorigenesis has been heavily studied and characterized, but its role in human breast cancer remains elusive. Although Wnt inhibitors are in early clinical development, it is unclear whether they will be of therapeutic benefit to breast cancer patients, and subsequently, to which ones. To address this, we generated a panel of Wnt reporting human breast cancer cell lines and identified a previously unrecognized enrichment for the ability to respond to Wnt in the basal B or claudin-low subtype, which has a poor prognosis and no available targeted therapies. By co-injecting Wnt3A expressing human mammary fibroblasts with human breast cancer cell lines into mouse mammary fat pads, we showed that elevated paracrine Wnt signaling was correlated with accelerated tumor growth. Using this heterotypic system and a dual lentiviral reporter system that enables simultaneous real-time measurement of both Wnt-responsive cells and bulk tumor cells, we analyzed the outcome of elevated Wnt signaling in patient-derived xenograft (PDX) models. Interestingly, the PDX models exhibited responses not observed in the cell lines analyzed. Exogenous WNT3A promoted tumor growth in one human epidermal growth factor receptor 2-overexpressing PDX line but inhibited growth in a second PDX line obtained from a patient with triple-negative breast cancer. Tumor suppression was associated with squamous differentiation in the latter. Thus, our work suggests that paracrine Wnt signaling can either fuel or repress the growth of human breast cancers depending on yet to be determined aspects of the molecular pathways they express.

摘要

Wnt 信号在小鼠乳腺发育和肿瘤发生中的作用已经得到了深入的研究和描述,但它在人类乳腺癌中的作用仍然难以捉摸。尽管 Wnt 抑制剂正在早期临床开发中,但尚不清楚它们是否对乳腺癌患者具有治疗益处,以及对哪些患者具有治疗益处。为了解决这个问题,我们生成了一组 Wnt 报告人源乳腺癌细胞系,并确定了以前未被认识到的对 Wnt 的反应能力在基底 B 或 Claudin-low 亚型中的富集,该亚型预后不良,且没有可用的靶向治疗方法。通过将表达 Wnt3A 的人乳腺成纤维细胞与人类乳腺癌细胞系共注射到小鼠乳腺脂肪垫中,我们表明,升高的旁分泌 Wnt 信号与肿瘤生长加速相关。使用这种异质系统和双慢病毒报告系统,我们能够同时实时测量 Wnt 反应性细胞和肿瘤细胞的总体,可以分析升高的 Wnt 信号在患者来源的异种移植(PDX)模型中的结果。有趣的是,PDX 模型表现出与分析的细胞系中观察到的不同的反应。外源性 WNT3A 促进了一个人表皮生长因子受体 2 过表达 PDX 系的肿瘤生长,但抑制了第二个 PDX 系的生长,该 PDX 系来自一名患有三阴性乳腺癌的患者。后者的肿瘤抑制与鳞状分化有关。因此,我们的工作表明,旁分泌 Wnt 信号可以根据它们表达的分子途径的尚未确定的方面来促进或抑制人类乳腺癌的生长。

相似文献

1
Paracrine Wnt signaling both promotes and inhibits human breast tumor growth.旁分泌 Wnt 信号既能促进又能抑制人乳腺癌的生长。
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6991-6. doi: 10.1073/pnas.1303671110. Epub 2013 Apr 4.
2
Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine acyltransferase or Wnt secretion.Wnt 家族成员 4(WNT4)和 WNT3A 独立于刺猬酰基转移酶或 Wnt 分泌激活细胞自主 Wnt 信号。
J Biol Chem. 2019 Dec 27;294(52):19950-19966. doi: 10.1074/jbc.RA119.009615. Epub 2019 Nov 18.
3
The Wnt3a/β-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.Wnt3a/β-catenin/TCF7L2 信号轴降低了曲妥珠单抗对 HER2 阳性上皮性卵巢癌的敏感性。
Biochem Biophys Res Commun. 2020 Jun 4;526(3):685-691. doi: 10.1016/j.bbrc.2020.03.154. Epub 2020 Apr 3.
4
Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.Wnt/β- 连环蛋白信号通路的小分子拮抗剂在 Her2/Neu 小鼠乳腺癌模型中靶向乳腺癌起始细胞。
PLoS One. 2012;7(3):e33976. doi: 10.1371/journal.pone.0033976. Epub 2012 Mar 28.
5
GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.GPNMB 通过增强 PI3K/AKT/mTOR 信号通路和 β-连环蛋白活性来增强 Wnt-1 介导的乳腺癌起始和生长。
Oncogene. 2019 Jun;38(26):5294-5307. doi: 10.1038/s41388-019-0793-7. Epub 2019 Mar 26.
6
Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.成纤维细胞自分泌 WNT2 信号促进结直肠癌进展。
Oncogene. 2017 Sep 28;36(39):5460-5472. doi: 10.1038/onc.2017.144. Epub 2017 May 29.
7
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.转化生长因子-β(TGF-β)重塑肿瘤相关成纤维细胞的代谢以促进肿瘤生长:将 TGF-β 信号与“Warburg-like”肿瘤代谢和 L-乳酸生成联系起来。
Cell Cycle. 2012 Aug 15;11(16):3019-35. doi: 10.4161/cc.21384. Epub 2012 Aug 9.
8
β-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells.β-连环蛋白去乙酰化对于 WNT 诱导的乳腺癌细胞增殖是必需的。
Mol Med Rep. 2014 Mar;9(3):973-8. doi: 10.3892/mmr.2014.1889. Epub 2014 Jan 8.
9
Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.氯硝柳胺通过抑制Wnt/β-连环蛋白信号通路,使三阴性乳腺癌细胞对电离辐射敏感。
Oncotarget. 2016 Jul 5;7(27):42126-42138. doi: 10.18632/oncotarget.9704.
10
Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.自噬调节因子BECN1抑制由WNT1激活和产后引起的乳腺肿瘤发生。
Autophagy. 2014;10(11):2036-52. doi: 10.4161/auto.34398. Epub 2014 Oct 30.

引用本文的文献

1
Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma.经典型和多形性浸润性小叶癌肿瘤微环境中癌症相关成纤维细胞表型的探索
Front Oncol. 2023 Dec 21;13:1281650. doi: 10.3389/fonc.2023.1281650. eCollection 2023.
2
Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer.信号通路与肿瘤微环境组分的相互作用:在结直肠癌中的矛盾角色。
Int J Mol Sci. 2023 Mar 15;24(6):5600. doi: 10.3390/ijms24065600.
3
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.诊断后使用他汀类药物与乳腺癌特异性死亡率:基于人群的队列研究。
Breast Cancer Res Treat. 2023 May;199(1):195-206. doi: 10.1007/s10549-022-06815-w. Epub 2023 Mar 17.
4
Non-coding RNA-related antitumor mechanisms of marine-derived agents.海洋来源药物的非编码RNA相关抗肿瘤机制
Front Pharmacol. 2022 Dec 1;13:1053556. doi: 10.3389/fphar.2022.1053556. eCollection 2022.
5
Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer.微小RNA/长链非编码RNA与Wnt/β-连环蛋白轴相互交织在调节三阴性乳腺癌发病机制中的作用
Front Pharmacol. 2022 Jun 24;13:814971. doi: 10.3389/fphar.2022.814971. eCollection 2022.
6
Association of statin use with clinical outcomes in patients with triple-negative breast cancer.他汀类药物的使用与三阴性乳腺癌患者临床结局的关联。
Cancer. 2021 Nov 15;127(22):4142-4150. doi: 10.1002/cncr.33797. Epub 2021 Aug 3.
7
Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.肿瘤相关成纤维细胞异质性:免疫微环境重塑中不可忽视的因素。
Front Immunol. 2021 Jul 8;12:671595. doi: 10.3389/fimmu.2021.671595. eCollection 2021.
8
Opposing effects of Wnt/β-catenin signaling on epithelial and mesenchymal cell fate in the developing cochlea.Wnt/β-catenin 信号对发育中耳蜗上皮细胞和间充质细胞命运的相反作用。
Development. 2021 Jun 1;148(11). doi: 10.1242/dev.199091.
9
Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling.癌相关成纤维细胞衍生的 SDF-1 通过 CXCR4/β-catenin/PPARδ 信号诱导肺腺癌上皮间质转化。
Cell Death Dis. 2021 Feb 26;12(2):214. doi: 10.1038/s41419-021-03509-x.
10
Cancer-Associated Fibroblast Subgroups Showing Differential Promoting Effect on HNSCC Progression.显示对HNSCC进展有不同促进作用的癌症相关成纤维细胞亚群。
Cancers (Basel). 2021 Feb 6;13(4):654. doi: 10.3390/cancers13040654.

本文引用的文献

1
Use of a molecular genetic platform technology to produce human Wnt proteins reveals distinct local and distal signaling abilities.利用分子遗传平台技术生产人类 Wnt 蛋白揭示了独特的局部和远程信号转导能力。
PLoS One. 2013;8(3):e58395. doi: 10.1371/journal.pone.0058395. Epub 2013 Mar 13.
2
Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.Wnt3 的表达激活了 Wnt/β-catenin 通路,并促进了曲妥珠单抗耐药的 HER2 过表达乳腺癌细胞中的 EMT 样表型。
Mol Cancer Res. 2012 Dec;10(12):1597-606. doi: 10.1158/1541-7786.MCR-12-0155-T. Epub 2012 Oct 15.
3
Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression.经典 Wnt 信号通路调控 Slug 活性,并将上皮-间充质转化与表观遗传的乳腺癌 1 型,早发(BRCA1)抑制联系起来。
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16654-9. doi: 10.1073/pnas.1205822109. Epub 2012 Sep 24.
4
Comprehensive molecular characterization of human colon and rectal cancer.全面的人类结肠和直肠癌分子特征分析。
Nature. 2012 Jul 18;487(7407):330-7. doi: 10.1038/nature11252.
5
Wnt/β-catenin signaling and disease.Wnt/β-连环蛋白信号通路与疾病
Cell. 2012 Jun 8;149(6):1192-205. doi: 10.1016/j.cell.2012.05.012.
6
Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse.Wnt/β-连环蛋白信号通路在正常和肿瘤性乳腺组织中的激活状态:与人及鼠的 HER2/neu 表达的关系。
PLoS One. 2012;7(3):e33421. doi: 10.1371/journal.pone.0033421. Epub 2012 Mar 23.
7
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.从患有乳腺癌的女性身上获得的肿瘤移植物真实地反映了肿瘤的病理、生长、转移和疾病结果。
Nat Med. 2011 Oct 23;17(11):1514-20. doi: 10.1038/nm.2454.
8
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.β-连环蛋白通路在乳腺癌中的激活与三阴性表型相关,但与 CTNNB1 突变无关。
Mod Pathol. 2011 Feb;24(2):209-31. doi: 10.1038/modpathol.2010.205. Epub 2010 Nov 12.
9
Key signaling nodes in mammary gland development and cancer: β-catenin.乳腺发育和癌症中的关键信号节点:β-连环蛋白。
Breast Cancer Res. 2010;12(6):213. doi: 10.1186/bcr2723. Epub 2010 Nov 3.
10
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.Claudin-low 型乳腺癌的表型和分子特征。
Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2.